As exercise preferentially mobilizes effector lymphocytes, including T-cells with a CD3+CD56+ phenotype (35), we hypothesized that exercise would also have adjuvant effects in manufacturing CIK cells that could be utilized more effectively in treating blood cancers. The gene discussed is NCAM1; the disease is hematopoietic and lymphoid system neoplasm.